EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions

Xinyan Zou, Xinfu Zou, Longxia Gao, Hanqing Zhao

Frontiers in Cellular and Infection Microbiology · 07.08.2024 · 14

DOI: 10.3389/fcimb.2024.1430586 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 07.08.2024. Verfasst von Xinyan Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Hebei University, Baoding, Hebei, China. Hauptthemen laut MEDLINE: Psoriasis, Gastrointestinal Microbiome, Medicine, Chinese Traditional, Fecal Microbiota Transplantation. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is one of the most common autoimmune skin diseases. Increasing evidence shows that alterations in the diversity and function of microbiota can participate in the pathogenesis of psoriasis through various pathways and mechanisms.

Objective

To review the connection between microbial changes and psoriasis, how microbial-targeted therapy can be used to treat psoriasis, as well as the potential of prebiotics, probiotics, synbiotics, fecal microbiota transplantation, diet, and Traditional Chinese Medicine as supplementary and adjunctive therapies.

Methods

Literature related to the relationship between psoriasis and gut microbiota was searched in PubMed and CNKI.

Results

Adjunct therapies such as dietary interventions, traditional Chinese medicine, and probiotics can enhance gut microbiota abundance and diversity in patients with psoriasis. These therapies stimulate immune mediators including IL-23, IL-17, IL-22, and modulate gamma interferon (IFN-γ) along with the NF-kB pathway, thereby suppressing the release of pro-inflammatory cytokines and ameliorating systemic inflammatory conditions.

Conclusion

This article discusses the direction of future research and clinical treatment of psoriasis from the perspective of intestinal microbiota and the mechanism of traditional Chinese medicine, so as to provide clinicians with more comprehensive diagnosis and treatment options and bring greater hope to patients with psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisGastrointestinal MicrobiomeMedicine, Chinese TraditionalFecal Microbiota TransplantationProbioticsHumansPrebioticsCytokinesInterleukin-17

Stichwörter der Autor:innen

gut microbiotapathogenesispsoriasistargeted therapytraditional Chinese medicine

Substanzen

PrebioticsCytokinesInterleukin-17

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Hebei University, Baoding, Hebei, China.
  • First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Zitieren

APA

Zou, X., Zou, X., Gao, L., & Zhao, H. (2024). Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1430586

Vancouver

Zou X, Zou X, Gao L, Zhao H. Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1430586

BibTeX
@article{Zou2024,
  author = {Zou, Xinyan and Zou, Xinfu and Gao, Longxia and Zhao, Hanqing},
  title = {Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1430586}
}
Kostenlos starten →